Strata Critical Medical, Inc. (SRTA) — Strategic Asset Allocation Index

Latest as of December 2022: 0.1%

Strata Critical Medical, Inc. (SRTA) has a Strategic Asset Allocation Index of 0.1% as of December 2022. Strategic assets (PP&E of $- plus long-term investments of $390.00K) total $390.00K, measured against net assets of $274.49 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.

SAAI

0.1%
Strategic Assets / Net Assets

Strategic Assets

$390.00K
PP&E + LT Investments

PP&E

$-
USD

Net Assets

$274.49 Million
USD

Strata Critical Medical, Inc. Strategic Asset Allocation Index (2021–2022)

This chart shows how Strata Critical Medical, Inc.'s Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of December 2022, the index stands at 0.1%, representing strategic assets of $390.00K against net assets of $274.49 Million USD. Explore Strata Critical Medical, Inc. (SRTA) cash flow conversion to assess how effectively this company generates cash.

Annual Strategic Asset Allocation Index for Strata Critical Medical, Inc. (2021–2022)

The table below presents the year-by-year Strategic Asset Allocation Index for Strata Critical Medical, Inc. from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Strata Critical Medical, Inc..

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2022 0.1% $390.00K $- $390.00K $274.49 Million ▲ +0.1 pp
2021 0.1% $200.00K $- $200.00K $291.37 Million
pp = percentage points